Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

51.000
+1.3602.74%
Volume:37.24M
Turnover:1.87B
Market Cap:211.40B
PE:37.67
High:51.000
Open:49.500
Low:48.620
Close:49.640
52wk High:51.550
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.90
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.354
ROE:11.64%
ROA:6.88%
PB:3.84
PE(LYR):37.67
PS:8.32

Loading ...

TOT Biopharm proposes Deloitte as new auditor as PwC retires

Reuters
·
Jun 04

WUXI BIO Issues 0.10 Million New Shares Under Pre-IPO Options, Repurchases 1.51 Million Shares for HKD 49.89 Million

Bulletin Express
·
Jun 03

WUXI BIO Executes Share Buyback, Spending Nearly HK$50 Million on June 3

Stock News
·
Jun 03

WuXi Biologics Reports Marginal Share Increase and Ongoing Buyback in May 2026 Monthly Return

Bulletin Express
·
Jun 03

Major Tech and Pharma Stocks Decline in Hong Kong Market

Deep News
·
Jun 03

WuXi Biologics makes CDP Supplier Engagement Assessment A List for second straight year

Reuters
·
Jun 03

Movement Alert|WuXi Biologics Declines 3.36% in Regular Trading, Trading at 33.66 HKD

Market Focus
·
Jun 03

Wuxi Biologics (Cayman) Stock Climbs 1.5% in Hong Kong

Dow Jones
·
Jun 02

Analyst Reiterates Outperform Rating and Price Target for WUXI BIO

Stock News
·
Jun 02

WuXi Biologics named to CDP Supplier Engagement Assessment A List for second straight year

Reuters
·
Jun 02

WUXI BIO (02269) Executes Share Buyback Worth HK$49.91 Million on June 1

Stock News
·
Jun 01

WuXi Biologics launches HK$49.91 million share buyback; minor option exercise lifts outstanding shares to 4.14 billion

Bulletin Express
·
Jun 01

Wuxi Biologics (Cayman) Stock Rises 3.8% in Hong Kong

Dow Jones
·
Jun 01

WUXI BIO Shares Surge Over 4% on Strong Project Wins and Confirmed Revenue Outlook

Stock News
·
Jun 01

BUZZ-WuXi Biologics hits 6-week high on confidence in delivering FY26 guidance

Reuters
·
Jun 01

Stock Track | WuXi Biologics Soars 5.28% in Intraday Trading on Share Buyback Execution and Strong Project Pipeline

Stock Track
·
Jun 01

Movement Alert|WuXi Biologics Rises 3.06% in Regular Trading, USD 400 Million Buyback Ongoing with 69 New Projects Added in First Four Months

Market Focus
·
Jun 01

Wuxi Biologics Adds 69 Projects In Jan-April, Maintains Expected Revenue Growth

Reuters
·
May 31

WuXi Biologics Says Added 69 New Projects in Jan-April, Maintains Expected Revenue Growth of 13-17% Y/Y

THOMSON REUTERS
·
May 31

WuXi Bio Buys Back 1.51 Million Shares on 29 May; Aggregate Repurchases Under 2025 Mandate Reach 27.69 Million

Bulletin Express
·
May 29